Stay updated with breaking news from Steno Type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Myocardial performance index, a heart-function metric derived from echo findings, significantly boosted the ability to predict incident CVD, especially heart failure, in people with type 1 diabetes.
Investigators have found that SGLT2 inhibitors decrease risk for long-term CVD and end-stage kidney disease in patients with type 1 diabetes.
Investigators have found that SGLT2 inhibitors decrease risk for cardiovascular disease and end-stage kidney disease in patients with type 1 diabetes.